PD-Rx Pharmaceuticals Inc (OTC: PDRX), a publicly held corporation that provides pharmaceutical and management strategies to the healthcare industry, yesterday announced its onetime dividend.
The company declared a dividend of USD2.20 per share.
The dividend will be paid to shareholders of record at 30 November 2018 on 12 December 2018.
Pfizer' board approves higher quarterly cash dividend and share repurchase programme
PURE Bioscience announces unchanged USD0.04 per share for Q1 fiscal 2019 Q1
Amgen signs joint initiative with Direct Relief
Tenax Therapeutics Closes USD 10m Underwritten Offering
SQI Diagnostics incurs higher net loss of USD7.437m for fiscal 2018
Amgen posts 10% rise in Q1 2019 dividend
Magellan Health anticipates 2019 net income in the USD52m to USD79m range